Cell Biologique™ - London

23/10/2026

When I started examining post-procedure biopsies more systematically, I noticed something counterintuitive.

Two clients with identical treatments, identical aftercare, completely different scar outcomes.

The difference wasn't technique. It wasn't the product protocol. It was the biological markers we weren't routinely measuring.

Three specific cellular signals determine whether scar tissue remodels cleanly or stays thickened:

✅ TGF-β1 expression levels
this growth factor drives fibroblast activity. When it stays elevated past day 14, you see persistent collagen deposition and fibrous tissue. The RESOLVE phase in the bioRegen framework targets this directly, downregulating inflammatory signaling before it locks into a pro-fibrotic state.

✅ myofibroblast persistence
these contractile cells should peak at day 7-10, then quiet down. If they persist beyond day 21, tissue stays contracted and thickened. The difference between temporary firmness and permanent texture change often comes down to whether resolution pathways activate on schedule.

✅ matrix metalloproteinase balance
MMPs break down old collagen so new, organized tissue can form. When the ratio of MMPs to their inhibitors (TIMPs) stays suppressed, remodeling stalls. You get disorganized scar instead of restored architecture.

This is why the bioRegen framework sequences interventions around biological timing, not arbitrary product steps.

PROTECT stabilizes the wound environment immediately.

RESOLVE guides the transition from inflammation to resolution before fibrosis sets in.

RESTORE and REMODEL support organized tissue architecture as the extracellular matrix rebuilds.

The procedure does not determine the outcome. The biological response determines the outcome.

When you understand these markers, inconsistent healing starts making sense, and your clinical reasoning becomes predictable.

Save this if you want to approach recovery with more precision than protocol.

21/10/2026

Most scar protocols jump straight from injury to repair.

They skip the resolve phase entirely, and that's where the outcome is decided.

Here's what's actually happening in your client's skin:

✅ protect phase , stabilise the barrier, prevent infection, calm acute inflammation
✅ resolve phase , clear damaged cells, redirect inflammatory signals, prepare the tissue for clean repair
✅ restore phase , rebuild collagen, restore structural integrity
✅ remodel phase , refine texture, strengthen the matrix long-term

but when you bypass resolve, you're asking the skin to build new tissue on top of unresolved cellular debris and lingering inflammation.

The result? Scarring that could have been prevented, healing that takes twice as long, and clients who lose confidence in the protocol.

The resolve phase isn't passive waiting. It's active cellular communication, clearing the way for predictable regeneration.

That's the phase most practitioners don't even know exists, and it's the difference between a scar that fades and one that stays.

If you want to understand how to support each phase with evidence-based reasoning instead of guessing, comment RESOLVE and I'll send you the breakdown.

19/10/2026

I used to start scar protocols the same way most practitioners do: assess the scar tissue itself, choose a modality, begin treatment.

Then I'd see inconsistent recovery. Same technique, different outcomes. The variable wasn't the treatment. It was the cellular environment before we even started.

Now I assess three biological markers first:

1. Inflammation resolution capacity , is the tissue still stuck in an inflammatory loop, or has it moved into the resolve phase? If inflammatory mediators are still elevated, any intervention can trigger a hypertrophic response. I look at redness persistence, warmth, tactile feedback.

2. Vascular integrity and perfusion , compromised microcirculation means poor nutrient delivery and waste removal. The tissue can't support remodelling if it's not adequately perfused. I assess capillary refill, temperature gradients, tissue turgor.

3. Fibroblast activity and collagen architecture , is the tissue laying down organised collagen, or chaotic scar matrix? This tells me whether we're working with a recovery-ready environment or one that needs structural support first. I palpate for texture, elasticity, directional tension.

These checkpoints give me a recovery trajectory before I choose a single product or protocol. The scar tissue is the outcome. The cellular response is the determinant.

If you want to move from guessing to predicting, these markers change everything.

Save this if you're ready to assess biology before starting treatment.

26/09/2026

I used to believe stronger peels gave faster results, until I saw the post-inflammatory cascade under the microscope.

For years, I approached chemical peels the way most of us were trained: depth equals efficacy. Stronger acid, faster turnover, more dramatic before-and-after photos.

Then I started really looking at what was happening at the cellular level during recovery.

What I saw changed everything.

The inflammatory response wasn't just a side effect to manage. It was the determining factor in whether a client healed with smooth, resilient skin or prolonged redness, pigment rebound, and barrier compromise.

The biological response determines the outcome. Not the peel strength. Not the percentage on the bottle.

This shift led me to rebuild my entire approach around cellular communication. Instead of chasing depth, I started asking: how do I support the cells' ability to resolve inflammation efficiently, restore barrier integrity predictably, and remodel tissue without triggering a prolonged repair cascade?

That question became the foundation of the BioRegen™ framework: protect, resolve, restore, remodel.

Now my clients heal faster, with fewer complications and stronger long-term skin health. Not because I'm using gentler peels across the board, but because I understand the biology driving the outcome.

If you're ready to move beyond protocol and into clinical reasoning, you're exactly who I created Cell Biologique for.

Follow for more evidence-based insights that change the way you think about skin recovery.

23/09/2026

Most post-procedure protocols focus on what to apply.

Few address what the skin is actually doing at the cellular level, and when it needs specific support.

Here's the timeline I follow with every client, built around the biology of healing, not just product application.

It's designed to resolve inflammation efficiently, support the skin's natural recovery cascade, and set the foundation for genuine long-term resilience.

Phase 1: days 0-3 (protect)
your priority is protecting barrier integrity and preventing secondary inflammation. The skin is in acute response mode, vulnerable to environmental triggers, microbial challenge, and transepidermal water loss. Support hydration and microbial balance without occlusion that traps heat.

Phase 2: days 4-7 (resolve)
Inflammation should be resolving, not persisting. If redness, heat, or sensitivity continues beyond day 5, the biological response is stuck. This is where resolution mediators become critical. The goal is active resolution, not suppression.

Phase 3: days 8-21 (restore)
Cellular communication pathways reopen. The skin begins rebuilding structural proteins, restoring barrier lipids, and re-establishing microbial diversity. This is the window where evidence-based actives can genuinely support regeneration, not just sit on the surface.

Phase 4: weeks 4-12 (remodel)
long-term remodeling determines the final outcome. Collagen architecture, pigment regulation, and barrier resilience are all shaped during this phase. Consistency matters more than intensity.

The procedure does not determine the outcome. The biological response determines the outcome.

When you understand the timeline, you can guide it.

Save this timeline for optimal post-procedure care! 💛

21/09/2026

I've reviewed hundreds of post-needling protocols over the years, and most describe products, timings, even client aftercare instructions in impressive detail.

But when I ask a simple question, the room goes quiet:

when does proliferation peak after needling?

Because if you can't answer that, you're not working with the biology. You're working around it.

Here's what I mean:

❌ evidence-based doesn't mean you attended a CPD course.
❌ it doesn't mean the brand sent you a white paper.
❌ it doesn't mean the protocol worked on your last three clients.

✅ evidence-based means you understand the cellular timeline.
✅ it means you know when inflammation should resolve.
✅ it means you can explain why you're applying that serum on day three, not just that the trainer told you to.

The proliferation phase begins around 48-72 hours post-injury and peaks between days 5-7. That's when fibroblast activity, collagen synthesis, and angiogenesis are at their highest.

If your protocol doesn't align with that window, you're guessing.

And guessing leads to inconsistent outcomes, frustrated clients, and that nagging feeling that maybe the results weren't as predictable as they should have been.

This is why I built the bioRegen framework around cellular recovery phases, not product categories. Because the biological response determines the outcome, not the procedure.

If this resonates, save this. I'll be unpacking the full wound-healing cascade and how to apply it clinically in upcoming posts.

20/09/2026

This question reveals more about clinical reasoning than most continuing education courses.

Because the answer isn't either/or. It's sequential.

Barrier function tells you how vulnerable the skin is to the procedure you're about to perform. pH tells you whether the stratum corneum is primed to receive the peel evenly.

If you assess pH first but the barrier is compromised, you're stepping into unpredictable inflammatory territory. You might get absorption, but you're also inviting excessive reactivity, prolonged erythema, and inconsistent wound healing responses.

If you assess barrier function first, you're asking the right biological question before the aesthetic one: is this skin ready to handle controlled injury? Can it mount a predictable recovery response? Or are we layering stress onto an already dysregulated system?

That's the shift from trend-driven protocols to evidence-based clinical reasoning.

The procedure does not determine the outcome. The biological response determines the outcome.

If you're tired of inconsistent client outcomes and want to deepen your understanding of cellular recovery science, comment SCIENCE and I'll send you a framework that changes how you think about every treatment, not just peels.

19/09/2026

I spent years adjusting concentrations, trying to predict which client would heal beautifully and which would struggle.

Same peel. Same percentage. Wildly different outcomes.

Because the percentage of the acid was never the variable that mattered most.

The biological response of the skin was.

When we dose peels by concentration alone, we're working from a product-centered framework. We're assuming the treatment determines the outcome.

But it doesn't.

The skin's ability to mount an appropriate inflammatory response, resolve that inflammation efficiently, and communicate effectively at the cellular level , that determines the outcome.

Two clients can receive the same 30% peel:

❌ client A has compromised barrier function, dysregulated inflammation, and poor cellular communication. Result: prolonged erythema, delayed recovery, potential pigmentation.

✅ client B has optimized cellular resilience, balanced inflammatory pathways, and strong repair mechanisms. Result: predictable healing, minimal downtime, improved skin architecture.

Same percentage. Different biology. Different outcome.

This is why we built the BioRegen™ Cellular Recovery Framework around four biological phases , protect, resolve, restore, remodel , not around ingredient percentages or treatment protocols.

Because when you understand the biology of healing, you stop chasing concentrations and start optimizing responses.

You move from hoping for consistency to creating the conditions for predictable recovery.

The shift isn't about abandoning percentages entirely. It's about recognizing that concentration is one variable in a much larger biological equation.

And the practitioners who grasp this distinction are the ones delivering the outcomes that build trust, referrals, and long-term skin health.

What's your primary metric for peel efficacy? Tell us below. 💭

18/09/2026

16/09/2026

I ran a poll last week asking what you thought mattered most when choosing a peel: percentage or pH.

62% voted percentage.

And I get it. We've been conditioned to think higher percentage = stronger result.

But when you look at what's actually happening at the cellular level, the story changes completely.

The percentage tells you how much acid is in the bottle. But pH tells you how many hydrogen ions are free to interact with the skin. And that's what drives the biological response.

A 30% glycolic at pH 3.5 behaves very differently from a 30% glycolic at pH 2.0. Same percentage. Completely different tissue response.

When we look at histological evidence, we see that wound-healing cascades, inflammation pathways, and cellular communication are all governed by the skin's immediate biological environment, not just the concentration on the label.

This is why two clients can receive the same peel at the same percentage and have wildly different outcomes. You're not controlling for the variable that actually matters: the biological response.

Once you understand the relationship between pH, free acid concentration, and tissue behaviour, you stop chasing percentages and start designing protocols around predictable recovery.

That's the shift from product-focused thinking to biology-focused reasoning.

Was your vote for percentage? This histology will change your mind. Follow for more deep dives. 🚀